Libtayo Injection
Product Images NDC 61755-008

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Libtayo (NDC 61755-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Regeneron Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (350 mg/7 mL Vial Carton)

A survival probability Kaplan-Meier curve comparing cemiplimab with chemotherapy over 32 months. The y-axis shows probability of survival from 0.0 to 1.0, and the x-axis shows months from 0 to 32. Number of subjects at risk is listed below the x-axis for both treatments at various time points.*

FDA Label Image

Libtayo 02

Packaging label for LIBTAYO (cemiplimab-rwlc) injection, 350 mg/7 mL (50 mg/mL) single-dose vial. The label states it is for intravenous infusion after dilution and includes instructions to discard unused portions. Manufactured by Regeneron Pharmaceuticals, Inc., and labeled for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.